Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
Feasibility Assessment of the Blood Pressure Imager, a Continuous Blood Pressure Monitor Tufts University Recruiting N/A
150
Trial Size
0.00 0 miles
e-OPRA Implant System for Lower Limb Amputees Integrum Recruiting N/A
6
Trial Size
0.00 0 miles
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) Shockwave Medical, Inc. Recruiting N/A
334
Trial Size
1.21 1 miles
Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
2936
Trial Size
1.21 1 miles
A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea Foamix Ltd. Recruiting
3
Trial Phase
1500
Trial Size
1.21 1 miles
Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea Steward St. Elizabeth's Medical Center of Boston, Inc. Recruiting N/A
40
Trial Size
1.21 1 miles
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris Foamix Ltd. Recruiting
3
Trial Phase
1500
Trial Size
1.21 1 miles
Decision-Aid for Renal Therapy Pilot Trial Tufts University Recruiting N/A
62
Trial Size
1.21 1 miles
A Phase 2 Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) Velicept Therapeutics, Inc. Recruiting
2
Trial Phase
1200
Trial Size
1.21 1 miles
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin Menlo Therapeutics Inc. Recruiting
2
Trial Phase
200
Trial Size
1.21 1 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
1.29 1 miles
Early patient access single named patient program for the use of ulocuplumab for the treatment of multiple myeloma Dana-Farber Cancer Institute Available N/A
0
Trial Size
1.29 1 miles
Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
90
Trial Size
1.29 1 miles
GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer Gilead Sciences Recruiting
1
Trial Phase
150
Trial Size
1.29 1 miles
H3.3K27M Peptide Vaccine for Children With Newly Diagnosed DIPG and Other Gliomas University of California, San Francisco Recruiting
1
Trial Phase
29
Trial Size
1.29 1 miles
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
850
Trial Size
1.29 1 miles
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) Fox Chase Cancer Center Recruiting
2
Trial Phase
48
Trial Size
1.29 1 miles
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors Seattle Genetics, Inc. Recruiting
1
Trial Phase
158
Trial Size
1.29 1 miles
A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting UCB Pharma Recruiting
2
Trial Phase
60
Trial Size
1.29 1 miles
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma Dana-Farber Cancer Institute Recruiting
2
Trial Phase
40
Trial Size
1.29 1 miles
A Prospective Controlled Treatment Trial for Post-Traumatic Headaches Boston Children’s Hospital Recruiting
3
Trial Phase
63
Trial Size
1.29 1 miles
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) Bristol-Myers Squibb Recruiting
2
Trial Phase
65
Trial Size
1.29 1 miles
Veliparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
90
Trial Size
1.29 1 miles
A Study Evaluating Venetoclax in Combination With Azacitidine in Subjects With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS) AbbVie Recruiting
1
Trial Phase
56
Trial Size
1.29 1 miles
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies Novartis Recruiting
1
Trial Phase
175
Trial Size
1.29 1 miles
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer National Cancer Institute (NCI) Recruiting
1
Trial Phase
40
Trial Size
1.29 1 miles
A Phase 1 Study of SY-1365 in Adult Patients With Advanced Solid Tumors Syros Pharmaceuticals Recruiting
1
Trial Phase
70
Trial Size
1.29 1 miles
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer ARMO BioSciences Recruiting
3
Trial Phase
566
Trial Size
1.29 1 miles
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS Alliance Foundation Trials, LLC. Recruiting N/A
1200
Trial Size
1.29 1 miles
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) Michael J. Fox Foundation for Parkinson's Research Recruiting N/A
50
Trial Size
1.29 1 miles
A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) After Hypomethylating Agent-Failure AbbVie Recruiting
1
Trial Phase
68
Trial Size
1.29 1 miles
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Boehringer Ingelheim Recruiting
3
Trial Phase
600
Trial Size
1.29 1 miles
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas University of California, San Francisco Recruiting
2
Trial Phase
42
Trial Size
1.29 1 miles
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
50
Trial Size
1.29 1 miles
A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia Dana-Farber Cancer Institute Recruiting
1
Trial Phase
38
Trial Size
1.29 1 miles
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) AbbVie Recruiting
3
Trial Phase
411
Trial Size
1.29 1 miles
A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
88
Trial Size
1.29 1 miles
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease Incyte Corporation Recruiting
3
Trial Phase
436
Trial Size
1.29 1 miles
Ribociclib (LEE011) Rollover Study for Continued Access Novartis Recruiting
2
Trial Phase
40
Trial Size
1.29 1 miles
A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA Tracon Pharmaceuticals Inc. Recruiting
3
Trial Phase
124
Trial Size
1.29 1 miles
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma University of California, San Francisco Recruiting
1
Trial Phase
18
Trial Size
1.29 1 miles
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy National Cancer Institute (NCI) Recruiting
3
Trial Phase
766
Trial Size
1.29 1 miles
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia Joslin Diabetes Center Recruiting
1
Trial Phase
40
Trial Size
1.29 1 miles
Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Novartis Recruiting
2
Trial Phase
110
Trial Size
1.29 1 miles
Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard Health Decisions Recruiting
3
Trial Phase
1000
Trial Size
1.29 1 miles
Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Eisai Inc. Recruiting
1
Trial Phase
110
Trial Size
1.29 1 miles
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor Dana-Farber Cancer Institute Recruiting
1
Trial Phase
60
Trial Size
1.29 1 miles
An Investigational Immuno-therapy Study of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Patients With High Grade Primary CNS Malignancies Bristol-Myers Squibb Recruiting
2
Trial Phase
170
Trial Size
1.29 1 miles
A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) BeiGene Recruiting
3
Trial Phase
167
Trial Size
1.29 1 miles
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors Novartis Recruiting
1
Trial Phase
105
Trial Size
1.29 1 miles
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
27
Trial Size
1.29 1 miles
Tesevatinib in Subjects With ADPKD Kadmon Corporation, LLC Recruiting
2
Trial Phase
100
Trial Size
1.29 1 miles
ErbB-2 Inhibitor ARRY-380 and Trastuzumab in Treating Patients With HER2-Positive Metastatic Colon or Rectal Cancer Academic and Community Cancer Research United Recruiting
2
Trial Phase
35
Trial Size
1.29 1 miles
Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients Sanofi Recruiting
3
Trial Phase
300
Trial Size
1.29 1 miles
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
22
Trial Size
1.29 1 miles
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Genentech, Inc. Recruiting
1
Trial Phase
572
Trial Size
1.29 1 miles
A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors Eli Lilly and Company Recruiting
1
Trial Phase
172
Trial Size
1.29 1 miles
Palbociclib In Progressive Brain Metastases Massachusetts General Hospital Recruiting
2
Trial Phase
30
Trial Size
1.29 1 miles
Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer University of California, San Diego Recruiting
2
Trial Phase
39
Trial Size
1.29 1 miles
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb Recruiting
3
Trial Phase
642
Trial Size
1.29 1 miles
Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavarin Gilead Sciences Recruiting
2
Trial Phase
50
Trial Size
1.29 1 miles
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Academic and Community Cancer Research United Recruiting
2
Trial Phase
280
Trial Size
1.29 1 miles
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer Dana-Farber Cancer Institute Recruiting
1
Trial Phase
60
Trial Size
1.29 1 miles
Bridging Community Gaps Photovoice Boston University Charles River Campus Recruiting N/A
180
Trial Size
1.29 1 miles
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI) National Institutes of Health Clinical Center (CC) Recruiting N/A
5000
Trial Size
1.29 1 miles
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Pfizer Recruiting
3
Trial Phase
640
Trial Size
1.29 1 miles
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors National Cancer Institute (NCI) Recruiting
2
Trial Phase
110
Trial Size
1.29 1 miles
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair National Cancer Institute (NCI) Recruiting
3
Trial Phase
700
Trial Size
1.29 1 miles
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen Hoffmann-La Roche Recruiting
3
Trial Phase
730
Trial Size
1.29 1 miles
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
180
Trial Size
1.29 1 miles
Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder Massachusetts General Hospital Recruiting N/A
60
Trial Size
1.29 1 miles
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma Bristol-Myers Squibb Recruiting
2
Trial Phase
200
Trial Size
1.29 1 miles
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Bristol-Myers Squibb Recruiting
2
Trial Phase
400
Trial Size
1.29 1 miles
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage Edge Therapeutics Inc Recruiting
3
Trial Phase
374
Trial Size
1.29 1 miles
Safety and Pharmacokinetics (PK) of Escalating Doses of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Locally Advanced or Metastatic Tumors Genentech, Inc. Recruiting
1
Trial Phase
300
Trial Size
1.29 1 miles
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia National Cancer Institute (NCI) Recruiting
1
Trial Phase
30
Trial Size
1.29 1 miles
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 University of Virginia Recruiting N/A
126
Trial Size
1.29 1 miles
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma Dana-Farber Cancer Institute Recruiting
2
Trial Phase
41
Trial Size
1.29 1 miles
Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
26
Trial Size
1.29 1 miles
A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults Janssen Vaccines & Prevention B.V. Recruiting
2
Trial Phase
150
Trial Size
1.29 1 miles
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, Bristol-Myers Squibb Recruiting
3
Trial Phase
340
Trial Size
1.29 1 miles
tACS for Amyloid-β Reduction in Alzheimer's Disease Beth Israel Deaconess Medical Center Recruiting N/A
20
Trial Size
1.29 1 miles
Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms H. Lee Moffitt Cancer Center and Research Institute Recruiting
1
Trial Phase
60
Trial Size
1.29 1 miles
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC Pfizer Recruiting
3
Trial Phase
280
Trial Size
1.29 1 miles
A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma Taiho Oncology, Inc. Recruiting
1
Trial Phase
243
Trial Size
1.29 1 miles
A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer AbGenomics B.V Taiwan Branch Recruiting
1
Trial Phase
54
Trial Size
1.29 1 miles
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
1300
Trial Size
1.29 1 miles
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer Array BioPharma Recruiting
3
Trial Phase
645
Trial Size
1.29 1 miles
Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest Beth Israel Deaconess Medical Center Recruiting
2
Trial Phase
100
Trial Size
1.29 1 miles
Phase 1 Study of BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Blueprint Medicines Corporation Recruiting
1
Trial Phase
115
Trial Size
1.29 1 miles
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity Sarcoma Alliance for Research through Collaboration Recruiting
2
Trial Phase
110
Trial Size
1.29 1 miles
A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson's Disease Hoffmann-La Roche Recruiting
2
Trial Phase
300
Trial Size
1.29 1 miles
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
310
Trial Size
1.29 1 miles
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide Oncopeptides AB Recruiting
3
Trial Phase
450
Trial Size
1.29 1 miles
Axicabtagene Ciloleucel Expanded Access Study Kite Pharma, Inc. Available N/A
0
Trial Size
1.29 1 miles
Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOL Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.29 1 miles
Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Genfit Recruiting
2
Trial Phase
45
Trial Size
1.29 1 miles
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes Beth Israel Deaconess Medical Center Recruiting
2
Trial Phase
20
Trial Size
1.29 1 miles
Minimal Residual Disease in Peripheral T-cell Lymphoma Washington University School of Medicine Recruiting N/A
42
Trial Size
1.29 1 miles
CISPLATIN + AZD-1775 In Breast Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
37
Trial Size
1.29 1 miles
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer Dana-Farber Cancer Institute Recruiting
1
Trial Phase
64
Trial Size
1.29 1 miles
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations National Cancer Institute (NCI) Recruiting
2
Trial Phase
209
Trial Size
1.29 1 miles
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Gilead Sciences Recruiting
3
Trial Phase
800
Trial Size
1.29 1 miles
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma Kite Pharma, Inc. Recruiting
2
Trial Phase
50
Trial Size
1.29 1 miles
CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors CanBas Co. Ltd. Recruiting
1
Trial Phase
42
Trial Size
1.29 1 miles
SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) Dana-Farber Cancer Institute Recruiting
1
Trial Phase
36
Trial Size
1.29 1 miles
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
430
Trial Size
1.29 1 miles
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia Massachusetts General Hospital Recruiting
2
Trial Phase
40
Trial Size
1.29 1 miles
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma Hoffmann-La Roche Recruiting
1
Trial Phase
86
Trial Size
1.29 1 miles
Nivolumab Plus Ipilimumab in Thyroid Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
54
Trial Size
1.29 1 miles
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma AIDS Malignancy Consortium Recruiting
2
Trial Phase
36
Trial Size
1.29 1 miles
A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer Hoffmann-La Roche Recruiting
1
Trial Phase
30
Trial Size
1.29 1 miles
Safety Study of Gene Modified Donor T-cells Following TCR + Alpha Beta Depleted Stem Cell Transplant Bellicum Pharmaceuticals Recruiting
1
Trial Phase
120
Trial Size
1.29 1 miles
PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor Joslin Diabetes Center Recruiting N/A
30
Trial Size
1.29 1 miles
Epigenetic Reprogramming in Relapse/Refractory AML Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
24
Trial Size
1.29 1 miles
"Recovery 4 US" - A Photovoice-based Social Media Program Boston University Charles River Campus Recruiting N/A
60
Trial Size
1.29 1 miles
Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) Genentech, Inc. Recruiting
1
Trial Phase
80
Trial Size
1.29 1 miles
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer Genentech, Inc. Recruiting
1
Trial Phase
130
Trial Size
1.29 1 miles
PERL Continuous Glucose Monitoring (CGM) Study Joslin Diabetes Center Recruiting N/A
300
Trial Size
1.29 1 miles
Circulating RNAs in Acute Congestive Heart Failure Massachusetts General Hospital Recruiting N/A
200
Trial Size
1.29 1 miles
Acute Kidney Injury Standardized Clinical Assessment and Management Plan for Renal Replacement Initiation Brigham and Women's Hospital Recruiting N/A
160
Trial Size
1.29 1 miles
mHealth Intervention for Older Adults Boston College Recruiting N/A
10
Trial Size
1.29 1 miles
JASPER Early Intervention for Tuberous Sclerosis University of California, Los Angeles Recruiting N/A
64
Trial Size
1.29 1 miles
Genomic Determinants and Shared Genetic Pathways of Periodontal Disease Tufts University Recruiting N/A
360
Trial Size
1.29 1 miles
Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes Joslin Diabetes Center Recruiting N/A
60
Trial Size
1.29 1 miles
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System Joslin Diabetes Center Recruiting N/A
200
Trial Size
1.29 1 miles
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting
1
Trial Phase
36
Trial Size
1.29 1 miles
Clinical Trial of SP-2577 in Patients With Relapsed or Refractory Ewing Sarcoma Salarius Pharmaceuticals, LLC Recruiting
1
Trial Phase
50
Trial Size
1.29 1 miles
Testing Psychosocial Treatment Planning Methods for Youth Anxiety and Depression Boston University Charles River Campus Recruiting N/A
52
Trial Size
1.29 1 miles
Brentuximab Vedotin and Nivolumab in Treating Participants With Early Stage Classic Hodgkin Lymphoma City of Hope Medical Center Recruiting
2
Trial Phase
264
Trial Size
1.29 1 miles
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia Clear Creek Bio, Inc. Recruiting
1
Trial Phase
27
Trial Size
1.29 1 miles
Improving Safety of Transitions to Skilled Nursing Care Using Videoconferencing Beth Israel Deaconess Medical Center Recruiting N/A
20
Trial Size
1.29 1 miles
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use Fenway Community Health Recruiting
4
Trial Phase
15
Trial Size
1.29 1 miles
Wellness Tool in Anesthesia Providers Beth Israel Deaconess Medical Center Recruiting N/A
108
Trial Size
1.29 1 miles
Investigation of 2X-121 in Patients With Advanced Ovarian Cancer Selected by the 2X-121 DRP® Oncology Venture Recruiting
2
Trial Phase
60
Trial Size
1.29 1 miles
3D Printer Modified CPAP Mask for Obstructive Sleep Apnea Beth Israel Deaconess Medical Center Recruiting N/A
20
Trial Size
1.29 1 miles
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC Odonate Therapeutics, Inc. Recruiting
2
Trial Phase
130
Trial Size
1.29 1 miles
Internet-based Videoconferencing to Address Alcohol Use and Pain Boston University Charles River Campus Recruiting N/A
8
Trial Size
1.29 1 miles
Acute Effect of Ventilatory Support During Exercise in Spinal Cord Injury Spaulding Rehabilitation Hospital Recruiting N/A
15
Trial Size
1.61 2 miles
Vaginal Estrogen for Asymptomatic Microscopic Hematuria Boston Urogynecology Associates Recruiting
4
Trial Phase
68
Trial Size
1.61 2 miles
Ventilatory Support to Improve Exercise Training in High Level Spinal Cord Injury Spaulding Rehabilitation Hospital Recruiting N/A
30
Trial Size
1.61 2 miles
Pulmonary Hemodynamics During Exercise - Research Network Medical University of Graz Recruiting N/A
1500
Trial Size
1.61 2 miles
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients APT Pharmaceuticals, Inc. Available N/A
0
Trial Size
1.65 2 miles
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy Marathon Pharmaceuticals, LLC Available N/A
0
Trial Size
1.65 2 miles
The ICON Study: Outcomes After FMT for Patients With IBD and CDI Brigham and Women's Hospital Recruiting
1
Trial Phase
50
Trial Size
1.65 2 miles
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer Dana-Farber Cancer Institute Recruiting N/A
100
Trial Size
1.65 2 miles
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Infants With Type1 Spinal Muscular Atrophy (Firefish) Hoffmann-La Roche Recruiting
2
Trial Phase
48
Trial Size
1.65 2 miles
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML Massachusetts General Hospital Recruiting
2
Trial Phase
64
Trial Size
1.65 2 miles
Measurement of Renal Functional Reserve Brigham and Women's Hospital Recruiting N/A
30
Trial Size
1.65 2 miles
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma Celgene Recruiting
2
Trial Phase
120
Trial Size
1.65 2 miles
Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma Massachusetts General Hospital Recruiting
2
Trial Phase
36
Trial Size
1.65 2 miles
SCP® Observational Study of the Knee Zimmer Biomet Recruiting N/A
1000
Trial Size
1.65 2 miles
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant Vanderbilt-Ingram Cancer Center Recruiting
2
Trial Phase
75
Trial Size
1.65 2 miles
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer (NSCLC) Genentech, Inc. Recruiting
2
Trial Phase
180
Trial Size
1.65 2 miles
Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA Brigham and Women's Hospital Recruiting
1
Trial Phase
5
Trial Size
1.65 2 miles
A Extension Study of Udenafil in Adolescents Mezzion Pharma Co. Ltd Recruiting
3
Trial Phase
300
Trial Size
1.65 2 miles
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma Hoffmann-La Roche Recruiting
2
Trial Phase
500
Trial Size
1.65 2 miles
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma Nanobiotix Recruiting
1
Trial Phase
96
Trial Size
1.65 2 miles
Novel Mobile Device Application to Improve Adherence National Institute of Allergy and Infectious Diseases (NIAID) Recruiting N/A
60
Trial Size
1.65 2 miles
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma Massachusetts General Hospital Recruiting
1
Trial Phase
60
Trial Size
1.65 2 miles
A Study to Investigate the Efficacy and Safety of RO5285119 in Participants With Autism Spectrum Disorder (ASD) Hoffmann-La Roche Recruiting
2
Trial Phase
300
Trial Size
1.65 2 miles
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) Duke University Recruiting
2
Trial Phase
110
Trial Size
1.65 2 miles
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia Children's Hospital Los Angeles Recruiting N/A
40
Trial Size
1.65 2 miles
Serum Hepcidin Immunoassay - Laboratory to Marketplace Intrinsic LifeSciences, LLC Recruiting N/A
650
Trial Size
1.65 2 miles
Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury Boston Children’s Hospital Recruiting N/A
250
Trial Size
1.65 2 miles
A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) Medical College of Wisconsin Recruiting
2
Trial Phase
150
Trial Size
1.65 2 miles
COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction Edwards Lifesciences Recruiting N/A
191
Trial Size
1.65 2 miles
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Massachusetts General Hospital Recruiting
2
Trial Phase
26
Trial Size
1.65 2 miles
Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients Shire Recruiting
3
Trial Phase
550
Trial Size
1.65 2 miles
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus Lupus Research Alliance Recruiting N/A
80
Trial Size
1.65 2 miles
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) in Patients With Select Advanced or Metastatic Solid Tumors Nektar Therapeutics Recruiting
1
Trial Phase
250
Trial Size
1.65 2 miles
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults AiCuris Anti-infective Cures GmbH Recruiting
2
Trial Phase
30
Trial Size
1.65 2 miles
Study of TSR-033 With an Anti-PD-1 Tesaro, Inc. Recruiting
1
Trial Phase
260
Trial Size
1.65 2 miles
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus. University of Florida Recruiting N/A
100
Trial Size
1.65 2 miles
Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study Xeltis Recruiting N/A
10
Trial Size
1.65 2 miles
A Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors Celgene Recruiting
2
Trial Phase
36
Trial Size
1.65 2 miles
Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery Brigham and Women's Hospital Recruiting N/A
100
Trial Size
1.65 2 miles
Gene Transfer for Sickle Cell Disease Boston Children’s Hospital Recruiting
1
Trial Phase
7
Trial Size
1.65 2 miles
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy Eisai Inc. Recruiting
2
Trial Phase
16
Trial Size
1.65 2 miles
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
58
Trial Size
1.65 2 miles
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Adults Who Are Virologically Suppressed Gilead Sciences Recruiting
3
Trial Phase
520
Trial Size
1.65 2 miles
Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies ArQule Recruiting
1
Trial Phase
16
Trial Size
1.65 2 miles
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) Actelion Recruiting
3
Trial Phase
300
Trial Size
1.65 2 miles
Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery AUSL Romagna Rimini Recruiting N/A
400
Trial Size
1.65 2 miles
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer National Cancer Institute (NCI) Recruiting
3
Trial Phase
739
Trial Size
1.65 2 miles
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes) Children's Hospital Medical Center, Cincinnati Recruiting N/A
400
Trial Size
1.65 2 miles
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome (SBS) Who Completed TED-C14-006 Shire Recruiting
3
Trial Phase
34
Trial Size
1.65 2 miles
Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma Massachusetts General Hospital Recruiting
2
Trial Phase
18
Trial Size
1.65 2 miles
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Biogen Recruiting
2
Trial Phase
320
Trial Size
1.65 2 miles
Pulmonary Rehabilitation Before Lung Cancer Resection Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
194
Trial Size
1.65 2 miles
Transplantation of Autologously Derived Mitochondria Following Ischemia Boston Children’s Hospital Recruiting N/A
6
Trial Size
1.65 2 miles
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure Brigham and Women's Hospital Recruiting
4
Trial Phase
9300
Trial Size
1.65 2 miles
Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket Dana-Farber Cancer Institute Recruiting
3
Trial Phase
130
Trial Size
1.65 2 miles
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
280
Trial Size
1.65 2 miles
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders Children's Research Institute Recruiting N/A
56
Trial Size
1.65 2 miles
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia Novartis Recruiting
2
Trial Phase
60
Trial Size
1.65 2 miles
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
783
Trial Size
1.65 2 miles
A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer Neon Therapeutics, Inc. Recruiting
1
Trial Phase
90
Trial Size
1.65 2 miles
Natural History Study of Cystathionine Beta-synthase Deficiency Homocystinuria (CBSDH) Orphan Technologies Ltd Recruiting N/A
100
Trial Size
1.65 2 miles
Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
1
Trial Phase
120
Trial Size
1.65 2 miles
Re-Evaluation of Systemic Early Neuromuscular Blockade and Transthoracic Ultrasound Assessment of the Diaphragm University Health Network, Toronto Recruiting N/A
180
Trial Size
1.65 2 miles
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection Gilead Sciences Recruiting
2
Trial Phase
200
Trial Size
1.65 2 miles
Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment Shire Recruiting
3
Trial Phase
351
Trial Size
1.65 2 miles
Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients Brainstorm-Cell Therapeutics Recruiting
3
Trial Phase
200
Trial Size
1.65 2 miles
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
37
Trial Size
1.65 2 miles
PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY Medtronic - MITG Recruiting N/A
1650
Trial Size
1.65 2 miles
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
204
Trial Size
1.65 2 miles
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps Hoffmann-La Roche Recruiting
3
Trial Phase
120
Trial Size
1.65 2 miles
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection AbbVie Recruiting
3
Trial Phase
110
Trial Size
1.65 2 miles
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation Bristol-Myers Squibb Recruiting
2
Trial Phase
150
Trial Size
1.65 2 miles
Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT) Biosense Webster, Inc. Recruiting
3
Trial Phase
367
Trial Size
1.65 2 miles
A Gene Transfer Study for Hemophilia A Spark Therapeutics Recruiting
1
Trial Phase
30
Trial Size
1.65 2 miles
A Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Sanofi Recruiting
3
Trial Phase
240
Trial Size
1.65 2 miles
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine Nektar Therapeutics Recruiting
3
Trial Phase
350
Trial Size
1.65 2 miles
PALISADE Follow-on Study (ARC004) Aimmune Therapeutics, Inc. Recruiting
3
Trial Phase
500
Trial Size
1.65 2 miles
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma Dana-Farber Cancer Institute Recruiting
2
Trial Phase
28
Trial Size
1.65 2 miles
Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) Medical College of Wisconsin Recruiting
2
Trial Phase
60
Trial Size
1.65 2 miles
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma National Cancer Institute (NCI) Recruiting
2
Trial Phase
70
Trial Size
1.65 2 miles
Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease University of Pittsburgh Recruiting
2
Trial Phase
20
Trial Size
1.65 2 miles
HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma Sidney Kimmel Comprehensive Cancer Center Recruiting
2
Trial Phase
35
Trial Size
1.65 2 miles
Bronchial NIR Image-guided Resection Brigham and Women's Hospital Recruiting
1
Trial Phase
100
Trial Size
1.65 2 miles
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease Takeda Recruiting
2
Trial Phase
80
Trial Size
1.65 2 miles
Flexible Electronics for Early Assessment Wyss Institute at Harvard University Recruiting N/A
120
Trial Size
1.65 2 miles
Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas Massachusetts General Hospital Recruiting
2
Trial Phase
30
Trial Size
1.65 2 miles
Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children Aimmune Therapeutics, Inc. Recruiting
3
Trial Phase
500
Trial Size
1.65 2 miles
A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma Eli Lilly and Company Recruiting
1
Trial Phase
37
Trial Size
1.65 2 miles
The Effect of Tooth Position During Orthodontic Treatment on the Apnea/ Hypopnea Index (AHI) Harvard School of Dental Medicine Recruiting N/A
54
Trial Size
1.65 2 miles
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Sidney Kimmel Comprehensive Cancer Center Recruiting
1
Trial Phase
30
Trial Size
1.65 2 miles
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors Genentech, Inc. Available N/A
0
Trial Size
1.65 2 miles
Phase 1 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET-Fusion Lung Cancer and Medullary Thyroid Cancer Loxo Oncology, Inc. Recruiting
1
Trial Phase
105
Trial Size
1.65 2 miles
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Gilead Sciences Recruiting
3
Trial Phase
800
Trial Size
1.65 2 miles
Efficacy and Safety of Dupilumab in Patients ≥12 to <18 Years of Age, With Moderate-to-Severe Atopic Dermatitis Regeneron Pharmaceuticals Recruiting
3
Trial Phase
240
Trial Size
1.65 2 miles
Study of Lorlatinib (PF-06463922) New Approaches to Neuroblastoma Therapy Consortium Recruiting
1
Trial Phase
40
Trial Size
1.65 2 miles
Strategies to Assist With Management of Pain University of Wisconsin, Madison Recruiting N/A
766
Trial Size
1.65 2 miles
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
42
Trial Size
1.65 2 miles
Cyclophosphamide and Alemtuzumab In Lymphoma Dana-Farber Cancer Institute Recruiting
1
Trial Phase
43
Trial Size
1.65 2 miles
Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer Dana-Farber Cancer Institute Recruiting
2
Trial Phase
152
Trial Size
1.65 2 miles
Short-Term Endogenous Hydrogen Sulfide Upregulation Brigham and Women's Hospital Recruiting N/A
40
Trial Size
1.65 2 miles
A Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Hoffmann-La Roche Recruiting
1
Trial Phase
94
Trial Size
1.65 2 miles
Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force Brigham and Women's Hospital Recruiting N/A
75
Trial Size
1.65 2 miles
PREG-MS: New England MS Pregnancy Registry Brigham and Women's Hospital Recruiting N/A
500
Trial Size
1.65 2 miles
Hypoglycemia and Autonomic Nervous System Function- B2 Brigham and Women's Hospital Recruiting N/A
14
Trial Size
1.65 2 miles
Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT Hummingbird Diagnostics Recruiting N/A
400
Trial Size
1.65 2 miles
Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2 Brigham and Women's Hospital Recruiting N/A
24
Trial Size
1.65 2 miles
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension AB2 Bio Ltd. Recruiting
3
Trial Phase
10
Trial Size
1.65 2 miles
Home Hospital for Suddenly Ill Adults Brigham and Women's Hospital Recruiting N/A
500
Trial Size
1.65 2 miles
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
1.65 2 miles
Chemotherapy and/or Metastasectomy in Treating Participants With Metastatic Colorectal Adenocarcinoma With Lung Metastases M.D. Anderson Cancer Center Recruiting
2
Trial Phase
365
Trial Size
1.65 2 miles
Multi-modal Neuroimaging in Children With Cerebral Palsy or Brachial Plexus Birth Palsy Boston Children’s Hospital Recruiting N/A
90
Trial Size
1.65 2 miles
Integrated Approaches to Health and Safety in a Dynamic Construction Work Environment Harvard School of Public Health Recruiting N/A
500
Trial Size
1.65 2 miles
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS Zynerba Pharmaceuticals, Inc. Recruiting
2
Trial Phase
300
Trial Size
1.65 2 miles
ATHN 8: PUPs Matter Study American Thrombosis and Hemostasis Network Recruiting N/A
250
Trial Size
1.65 2 miles
REtroperitoneal SArcoma Registry: an International Prospective Initiative Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting N/A
2000
Trial Size
1.65 2 miles
Treatment of Persistent Cough in IPF With Inhaled RVT-1601 Respivant Sciences Inc. Recruiting
2
Trial Phase
180
Trial Size
1.65 2 miles
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Columbia University Recruiting N/A
30
Trial Size
1.65 2 miles
Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain Dana-Farber Cancer Institute Recruiting N/A
10
Trial Size
1.65 2 miles
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer Dana-Farber Cancer Institute Recruiting N/A
10
Trial Size
1.65 2 miles
Microdevice for Evaluating Drug Response in Site in Lung Lesions Brigham and Women's Hospital Recruiting
1
Trial Phase
5
Trial Size
1.65 2 miles
Sebacia Postmarket Study of Real-World Use Sebacia, Inc. Recruiting N/A
125
Trial Size
1.95 2 miles
Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients Massachusetts Eye and Ear Infirmary Available N/A
0
Trial Size
1.96 2 miles
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Novartis Available N/A
0
Trial Size
1.96 2 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
1.96 2 miles
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Takeda Recruiting
2
Trial Phase
38
Trial Size
1.96 2 miles
A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF) Vertex Pharmaceuticals Incorporated Recruiting
3
Trial Phase
90
Trial Size
1.96 2 miles
Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure Jana Care Recruiting N/A
24
Trial Size
1.96 2 miles
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease Janssen Research & Development, LLC Recruiting
2
Trial Phase
450
Trial Size
1.96 2 miles
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients Massachusetts General Hospital Recruiting N/A
100
Trial Size
1.96 2 miles
Viekira Pak Treatment for Patient With Chronic Kidney Disease and Hepatitis C Massachusetts General Hospital Recruiting
4
Trial Phase
24
Trial Size
1.96 2 miles
RGX-314 Gene Therapy for Neovascular AMD Trial Regenxbio Inc. Recruiting
1
Trial Phase
18
Trial Size
1.96 2 miles
Evaluation of PET/MR in Patients Selected for Ablation Therapy Massachusetts General Hospital Recruiting
2
Trial Phase
150
Trial Size
1.96 2 miles
A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients Hope Pharmaceuticals Recruiting
3
Trial Phase
111
Trial Size
1.96 2 miles
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation Sanofi Recruiting
2
Trial Phase
243
Trial Size
1.96 2 miles
Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism Daiichi Sankyo, Inc. Recruiting
1
Trial Phase
132
Trial Size
1.96 2 miles
A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes Massachusetts General Hospital Recruiting N/A
60
Trial Size
1.96 2 miles
Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin Massachusetts General Hospital Recruiting N/A
100
Trial Size
1.96 2 miles
Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma Massachusetts General Hospital Recruiting N/A
40
Trial Size
1.96 2 miles
Imaging Genetics of Spasmodic Dysphonia Massachusetts Eye and Ear Infirmary Recruiting N/A
298
Trial Size
1.96 2 miles
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients Massachusetts General Hospital Recruiting N/A
20
Trial Size
1.96 2 miles
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep Massachusetts General Hospital Recruiting
2
Trial Phase
300
Trial Size
1.96 2 miles
Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant Massachusetts General Hospital Recruiting
4
Trial Phase
11
Trial Size
1.96 2 miles
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise Massachusetts General Hospital Recruiting N/A
40
Trial Size
1.96 2 miles
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly Chiasma, Inc. Recruiting
3
Trial Phase
50
Trial Size
1.96 2 miles
Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate Hope Pharmaceuticals Recruiting N/A
111
Trial Size
1.96 2 miles
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS Novartis Recruiting
1
Trial Phase
70
Trial Size
1.96 2 miles
A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement Vanderbilt University Medical Center Recruiting N/A
50
Trial Size
1.96 2 miles
Community Health Worker Care Transitions Study Massachusetts General Hospital Recruiting N/A
1200
Trial Size
1.96 2 miles
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis Squarex, LLC Recruiting
1
Trial Phase
94
Trial Size
1.96 2 miles
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC Massachusetts General Hospital Recruiting
1
Trial Phase
31
Trial Size
1.96 2 miles
Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Sanofi Recruiting
3
Trial Phase
360
Trial Size
1.96 2 miles
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer Hoffmann-La Roche Recruiting
2
Trial Phase
450
Trial Size
1.96 2 miles
Validation of Thermal Imaging to Detect Pneumonia Massachusetts General Hospital Recruiting N/A
138
Trial Size
1.96 2 miles
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma New York University School of Medicine Recruiting
2
Trial Phase
43
Trial Size
1.96 2 miles
QP ExCELs: MultiPole Pacing (MPP) Sub-Study Biotronik, Inc. Recruiting N/A
100
Trial Size
1.96 2 miles
A Clinical Study to Evaluate the KeraKlear Keratoprosthesis in Patients With Corneal Opacity KeraMed, Inc. Recruiting N/A
35
Trial Size
1.96 2 miles
Preoperative Radiotherapy and E7046 in Rectum Cancer Eisai Inc. Recruiting
1
Trial Phase
68
Trial Size
1.96 2 miles
A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine Astellas Pharma Inc Recruiting
1
Trial Phase
30
Trial Size
1.96 2 miles
Trial of H3B-6545, a Covalent Antagonist of Estrogen Receptor Alpha, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer Eisai Inc. Recruiting
1
Trial Phase
110
Trial Size
1.96 2 miles
A Text Messaging Program for Smokers in Primary Care Massachusetts General Hospital Recruiting
4
Trial Phase
206
Trial Size
1.96 2 miles
An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300) Stealth BioTherapeutics Inc. Recruiting N/A
300
Trial Size
1.96 2 miles
STOP Persistent AF Medtronic Atrial Fibrillation Solutions Recruiting N/A
225
Trial Size
1.96 2 miles
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot Duke University Recruiting
1
Trial Phase
40
Trial Size
1.96 2 miles
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects University of Florida Recruiting
3
Trial Phase
225
Trial Size
1.96 2 miles
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease Actelion Recruiting
2
Trial Phase
300
Trial Size
1.96 2 miles
Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects Actelion Recruiting
3
Trial Phase
134
Trial Size
1.96 2 miles
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy Boston Scientific Corporation Recruiting N/A
726
Trial Size
1.96 2 miles
A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and REGN2810 in Patients With Advanced Solid Tumors Sanofi Recruiting
1
Trial Phase
130
Trial Size
1.96 2 miles
REDUCE LAP-HF TRIAL II Corvia Medical Recruiting N/A
380
Trial Size
1.96 2 miles
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia Applied Genetic Technologies Corp Recruiting
1
Trial Phase
24
Trial Size
1.96 2 miles
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE Ampel BioSolutions, LLC Recruiting
4
Trial Phase
62
Trial Size
1.96 2 miles
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI Massachusetts General Hospital Recruiting N/A
85
Trial Size
1.96 2 miles
Treatment With Quetiapine for Youth With Substance Use Disorders and Bipolar Disorder Massachusetts General Hospital Recruiting
4
Trial Phase
56
Trial Size
1.96 2 miles
A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder Janssen Research & Development, LLC Recruiting N/A
208
Trial Size
1.96 2 miles
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD Massachusetts General Hospital Recruiting
4
Trial Phase
639
Trial Size
1.96 2 miles
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury Massachusetts General Hospital Recruiting N/A
50
Trial Size
1.96 2 miles
A Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis AbbVie Recruiting
2
Trial Phase
170
Trial Size
1.96 2 miles
A Collaborative Palliative and Leukemia Care Model for Patients With AML Receiving Non-Intensive Therapy Massachusetts General Hospital Recruiting N/A
320
Trial Size
1.96 2 miles
Primary Tumor Research and Outcome Network AO Clinical Investigation and Documentation Recruiting N/A
300
Trial Size
1.96 2 miles
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function Protalix Recruiting
3
Trial Phase
78
Trial Size
1.96 2 miles
Mucinex® for Treatment of Filamentary Keratitis Massachusetts Eye and Ear Infirmary Recruiting N/A
15
Trial Size
1.96 2 miles
Shift Work, Heredity, Insulin, and Food Timing Study Massachusetts General Hospital Recruiting N/A
1000
Trial Size
1.96 2 miles
Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder Massachusetts General Hospital Recruiting N/A
10
Trial Size
1.96 2 miles
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) Astellas Pharma Inc Available N/A
0
Trial Size
1.96 2 miles
A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer Massachusetts General Hospital Recruiting
2
Trial Phase
32
Trial Size
1.96 2 miles
Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients Retrophin, Inc. Recruiting
3
Trial Phase
82
Trial Size
1.96 2 miles
A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) Syntimmune, Inc. Recruiting
1
Trial Phase
16
Trial Size
1.96 2 miles
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. Flex Pharma, Inc. Recruiting
2
Trial Phase
120
Trial Size
1.96 2 miles
A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD) Massachusetts General Hospital Recruiting N/A
10
Trial Size
1.96 2 miles
Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS) Massachusetts General Hospital Recruiting
2
Trial Phase
30
Trial Size
1.96 2 miles
PREVENTion of Clot in Orthopaedic Trauma Major Extremity Trauma Research Consortium Recruiting
3
Trial Phase
12980
Trial Size
1.96 2 miles
A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma Massachusetts General Hospital Recruiting
2
Trial Phase
28
Trial Size
1.96 2 miles
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
4872
Trial Size
1.96 2 miles
Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone Massachusetts General Hospital Recruiting N/A
10
Trial Size
1.96 2 miles
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 1 New York University School of Medicine Recruiting N/A
102
Trial Size
1.96 2 miles
Study of LXH254 and LTT462 in NSCLC Novartis Recruiting
1
Trial Phase
75
Trial Size
1.96 2 miles
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Pfizer Recruiting
2
Trial Phase
132
Trial Size
1.96 2 miles
A Trial of Lenvatinib Plus Pembrolizumab in Subjects With Hepatocellular Carcinoma Eisai Inc. Recruiting
1
Trial Phase
30
Trial Size
1.96 2 miles
A Roll Over Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
200
Trial Size
1.96 2 miles
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) Massachusetts General Hospital Recruiting
4
Trial Phase
50
Trial Size
1.96 2 miles
Zoster Eye Disease Study New York University School of Medicine Recruiting
4
Trial Phase
1050
Trial Size
1.96 2 miles
Oxytocin and Cognitive Control in Adult ADHD Massachusetts General Hospital Recruiting
1
Trial Phase
24
Trial Size
1.96 2 miles
Molecular and Genetic Analysis of Lung Cancer Massachusetts General Hospital Recruiting N/A
10000
Trial Size
1.96 2 miles
A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease University of California, San Francisco Recruiting
2
Trial Phase
84
Trial Size
1.96 2 miles
Researching Emotions And Cardiac Health: Phase III Massachusetts General Hospital Recruiting N/A
75
Trial Size
1.96 2 miles
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) Incyte Corporation Recruiting
2
Trial Phase
120
Trial Size
1.96 2 miles
A Study of ABBV-927, an Immunotherapy, in Participants With Advanced Solid Tumors AbbVie Recruiting
1
Trial Phase
180
Trial Size
1.96 2 miles
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers Adaptimmune Recruiting
1
Trial Phase
22
Trial Size
1.96 2 miles
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Participants With Metastatic or Unresectable Locally Advanced Melanoma Hoffmann-La Roche Recruiting
3
Trial Phase
500
Trial Size
1.96 2 miles
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff Crestovo LLC Recruiting
2
Trial Phase
240
Trial Size
1.96 2 miles
Efficacy and Safety of Filgotinib in Adults With Active Non-Infectious Uveitis Gilead Sciences Recruiting
2
Trial Phase
110
Trial Size
1.96 2 miles
Phase 1B/2 Study in Subjects With Small to Medium Primary Choroidal Melanoma Aura Biosciences Recruiting
1
Trial Phase
24
Trial Size
1.96 2 miles
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation Massachusetts General Hospital Recruiting N/A
53
Trial Size
1.96 2 miles
A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes Massachusetts General Hospital Recruiting N/A
70
Trial Size
1.96 2 miles
Study of BIIB092 in Participants With Progressive Supranuclear Palsy Biogen Recruiting
2
Trial Phase
396
Trial Size
1.96 2 miles
Positive Psychology for Acute Coronary Syndrome Patients Massachusetts General Hospital Recruiting N/A
50
Trial Size
1.96 2 miles
AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) Amylyx Pharmaceuticals Inc. Recruiting
2
Trial Phase
132
Trial Size
1.96 2 miles
A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis. Aldeyra Therapeutics, Inc. Recruiting
3
Trial Phase
100
Trial Size
1.96 2 miles
AFPᶜ³³²T in Advanced HCC Adaptimmune Recruiting
1
Trial Phase
30
Trial Size
1.96 2 miles
Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study Massachusetts General Hospital Recruiting
1
Trial Phase
75
Trial Size
1.96 2 miles
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects With Resected Solid Tumors and in Combination With Pembrolizumab in Subjects With Unresectable Solid Tumors Moderna Therapeutics Recruiting
1
Trial Phase
90
Trial Size
1.96 2 miles
Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging Massachusetts General Hospital Recruiting N/A
60
Trial Size
1.96 2 miles
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma Hoffmann-La Roche Recruiting
3
Trial Phase
450
Trial Size
1.96 2 miles
Dose Escalation Study of mRNA 2416 for Intratumoral Injection to Patients With Advanced Malignancies Moderna Therapeutics Recruiting
1
Trial Phase
75
Trial Size
1.96 2 miles
Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents Massachusetts General Hospital Recruiting N/A
210
Trial Size
1.96 2 miles
Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy Massachusetts General Hospital Recruiting N/A
56
Trial Size
1.96 2 miles
ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) Ophthotech Corporation Recruiting
2
Trial Phase
60
Trial Size
1.96 2 miles
Natural History Study of CEP290-Related Retinal Degeneration Editas Medicine, Inc. Recruiting N/A
40
Trial Size
1.96 2 miles
Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders Massachusetts General Hospital Recruiting N/A
49
Trial Size
1.96 2 miles
A Study of VB-111 Combined With Paclitaxel vs. Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) Vascular Biogenics Ltd. operating as VBL Therapeutics Recruiting
3
Trial Phase
350
Trial Size
1.96 2 miles
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing Massachusetts General Hospital Recruiting N/A
224
Trial Size
1.96 2 miles
Depression and Body Image Distress Following Mastectomy With Reconstruction Massachusetts General Hospital Recruiting N/A
49
Trial Size
1.96 2 miles
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150] Hoffmann-La Roche Recruiting
3
Trial Phase
480
Trial Size
1.96 2 miles
SMART Program for Paroxysmal Atrial Fibrillation Massachusetts General Hospital Recruiting N/A
18
Trial Size
1.96 2 miles
The Effect of RNS60 on ALS Biomarkers Mario Negri Institute for Pharmacological Research Recruiting
2
Trial Phase
142
Trial Size
1.96 2 miles
Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy Massachusetts General Hospital Recruiting N/A
500
Trial Size
1.96 2 miles
Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome Massachusetts General Hospital Recruiting N/A
2000
Trial Size
1.96 2 miles
Retention in HIV Care for Hispanic Immigrants Massachusetts General Hospital Recruiting N/A
70
Trial Size
1.96 2 miles
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease Cour Pharmaceutical Development Company, Inc. Recruiting
1
Trial Phase
22
Trial Size
1.96 2 miles
Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients Midatech Pharma US Inc. Recruiting
4
Trial Phase
60
Trial Size
1.96 2 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
1.96 2 miles
Treatments for Anxiety: Meditation and Escitalopram Georgetown University Recruiting
4
Trial Phase
370
Trial Size
1.96 2 miles
Brexpiprazole Study University of Massachusetts, Worcester Recruiting
4
Trial Phase
80
Trial Size
1.96 2 miles
Does Use of Rapid Response EEG Impact Clinical Decision Making Ceribell Inc. Recruiting N/A
200
Trial Size
1.96 2 miles
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy Hoffmann-La Roche Recruiting
2
Trial Phase
100
Trial Size
1.96 2 miles
Collection of Breath and Sweat to Identify Indicators of Hypoglycemia Massachusetts General Hospital Recruiting
2
Trial Phase
24
Trial Size
1.96 2 miles
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis University of Iowa Recruiting N/A
860
Trial Size
1.96 2 miles
Photobiomodulation in Autism Spectrum Disorder (ASD) Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study Massachusetts General Hospital Recruiting N/A
210
Trial Size
1.96 2 miles
Myocardial Infarction, COmbined-device, Recovery Enhancement Study Johns Hopkins University Recruiting N/A
950
Trial Size
1.96 2 miles
Pilocarpine and Brimonidine in Patients With Monofocal Lenses Massachusetts Eye and Ear Infirmary Recruiting
1
Trial Phase
33
Trial Size
1.96 2 miles
Growth Hormone Dynamics and Cardiac Steatosis in HIV Massachusetts General Hospital Recruiting N/A
30
Trial Size
1.96 2 miles
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder Massachusetts General Hospital Recruiting N/A
500
Trial Size
1.96 2 miles
Imaging of LAA Thrombosis Massachusetts General Hospital Recruiting
1
Trial Phase
100
Trial Size
1.96 2 miles
MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms Massachusetts General Hospital Recruiting N/A
70
Trial Size
1.96 2 miles
A Phase 1 Clinical Trial of ARV-110 in Patients With Metastatic Castration-resistant Prostate Cancer. Arvinas Inc Recruiting
1
Trial Phase
36
Trial Size
1.96 2 miles
BMAC Use With Labral Repair Massachusetts General Hospital Recruiting N/A
40
Trial Size
1.96 2 miles
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum Massachusetts General Hospital Recruiting N/A
80
Trial Size
1.96 2 miles
Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds Rogers Sciences Inc. Recruiting N/A
12
Trial Size
1.96 2 miles
Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain Spaulding Rehabilitation Hospital Recruiting N/A
20
Trial Size
2.00 2 miles
Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy Spaulding Rehabilitation Hospital Recruiting N/A
10
Trial Size
2.00 2 miles
Evaluating the Role of Neuroinflammation in Low Back Pain Massachusetts General Hospital Recruiting
2
Trial Phase
145
Trial Size
2.00 2 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
2.00 2 miles
Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Spinal Cord Injury Patients Spaulding Rehabilitation Hospital Recruiting
2
Trial Phase
60
Trial Size
2.00 2 miles
Adhering to Dietary Approaches for Personal Taste (ADAPT), Exam 1 Tufts University Recruiting N/A
5000
Trial Size
2.41 2 miles
Study in Subjects With Light Chain (AL) Amyloidosis Prothena Therapeutics Ltd. Recruiting
2
Trial Phase
100
Trial Size
2.41 2 miles
Impact of Fever Prevention in Brain Injured Patients C. R. Bard Recruiting N/A
1176
Trial Size
2.41 2 miles
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Reata Pharmaceuticals, Inc. Recruiting
2
Trial Phase
210
Trial Size
2.41 2 miles
A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance Astellas Pharma Inc Recruiting
2
Trial Phase
222
Trial Size
2.41 2 miles
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Jazz Pharmaceuticals Recruiting
3
Trial Phase
400
Trial Size
2.41 2 miles
Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage Tufts Medical Center Recruiting
4
Trial Phase
10
Trial Size
2.41 2 miles
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics Genentech, Inc. Recruiting
1
Trial Phase
24
Trial Size
2.41 2 miles
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug AbbVie Recruiting
3
Trial Phase
1640
Trial Size
2.41 2 miles
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors Ipsen Recruiting N/A
100
Trial Size
2.41 2 miles
VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB Aerogen Pharma Limited Recruiting
2
Trial Phase
20
Trial Size
2.41 2 miles
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission Astellas Pharma Inc Recruiting
3
Trial Phase
354
Trial Size
2.41 2 miles
A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo Incyte Corporation Recruiting
2
Trial Phase
150
Trial Size
2.41 2 miles
Clinical Evaluation of a New Giomer Restorative System in Class V Restorations Tufts University School of Dental Medicine Recruiting N/A
50
Trial Size
2.41 2 miles
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis Janssen Research & Development, LLC Recruiting
3
Trial Phase
370
Trial Size
2.41 2 miles
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) (Morpheus-Gastric Cancer) Hoffmann-La Roche Recruiting
1
Trial Phase
357
Trial Size
2.41 2 miles
The TCF7L2 Gene: Dietary Prevention of T2DM Tufts University Recruiting N/A
40
Trial Size
2.41 2 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
2.41 2 miles
Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study Tufts Medical Center Recruiting N/A
30
Trial Size
2.41 2 miles
A Phase 2 Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease Eisai Inc. Recruiting
2
Trial Phase
31
Trial Size
2.44 2 miles
Development of an Intervention to Enhance Cancer Pain Management Massachusetts General Hospital Recruiting N/A
150
Trial Size
2.44 2 miles
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor Sera Prognostics, Inc. Recruiting N/A
4000
Trial Size
2.85 3 miles
Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center Boston Medical Center Recruiting N/A
50
Trial Size
2.85 3 miles
Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
1
Trial Phase
80
Trial Size
2.85 3 miles
Oral Versus Intravenous Sedation for Ocular Procedures Boston Medical Center Recruiting
4
Trial Phase
400
Trial Size
2.85 3 miles
Brentuximab Vedotin for Systemic Sclerosis National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
1
Trial Phase
24
Trial Size
2.85 3 miles
VCRC Tissue Repository University of Pennsylvania Recruiting N/A
1000
Trial Size
2.85 3 miles
FLUAD vs. Fluzone High-Dose Study Duke University Recruiting
4
Trial Phase
900
Trial Size
2.85 3 miles
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer National Cancer Institute (NCI) Recruiting
3
Trial Phase
1000
Trial Size
2.85 3 miles
Bio Electro Stimulation Therapy for Parkinson's Disease Boston University Recruiting N/A
66
Trial Size
2.85 3 miles
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy Pfizer Recruiting
3
Trial Phase
330
Trial Size
2.85 3 miles
Trial of Overminus Spectacle Therapy for Intermittent Exotropia Jaeb Center for Health Research Recruiting N/A
384
Trial Size
2.85 3 miles
Self-Management Using Text Messaging in a Homeless Population Boston University Recruiting N/A
60
Trial Size
2.85 3 miles
Patient Navigation in Cancer Survivorship at a Safety Net Institution Boston Medical Center Recruiting N/A
100
Trial Size
2.85 3 miles
A Randomized Multicenter Study for Isolated Skin Vasculitis University of Pennsylvania Recruiting
2
Trial Phase
90
Trial Size
2.85 3 miles
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors Medical University of South Carolina Recruiting N/A
184
Trial Size
2.85 3 miles
Clinical Transcriptomics in Systemic Vasculitis (CUTIS) University of Pennsylvania Recruiting N/A
50
Trial Size
2.85 3 miles
Genetics of Ehlers-Danlos Syndrome Boston University Recruiting N/A
60
Trial Size
2.85 3 miles
VAXCHORA Pediatric Study PaxVax, Inc. Recruiting
4
Trial Phase
525
Trial Size
2.85 3 miles
Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP) Boston University Recruiting N/A
100
Trial Size
2.85 3 miles
RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty Boston Scientific Corporation Recruiting
3
Trial Phase
396
Trial Size
2.85 3 miles
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
2
Trial Phase
320
Trial Size
2.85 3 miles
Multimodal Outcome CHAracterization in Comatose Cardiac Arrest Patients Registry and Tissue Repository Boston Medical Center Recruiting N/A
2500
Trial Size
2.85 3 miles
ATTR Expanded Access Program (EAP) by Ionis Ionis Pharmaceuticals, Inc. Available N/A
0
Trial Size
2.85 3 miles
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Genentech, Inc. Recruiting
2
Trial Phase
240
Trial Size
2.85 3 miles
Growing Together: Women in Opioid Treatment and Their Infants Boston University Charles River Campus Recruiting N/A
100
Trial Size
2.85 3 miles
Qualitative Analysis of Subject Experience of Nasal Polyps GlaxoSmithKline Recruiting N/A
30
Trial Size
3.45 3 miles
A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease ACADIA Pharmaceuticals Inc. Recruiting
2
Trial Phase
432
Trial Size
3.95 4 miles
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder Allergan Recruiting
3
Trial Phase
600
Trial Size
3.95 4 miles
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) LEO Pharma Recruiting
3
Trial Phase
780
Trial Size
3.95 4 miles
Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine Allergan Recruiting
3
Trial Phase
1650
Trial Size
3.95 4 miles
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder Allergan Recruiting
3
Trial Phase
500
Trial Size
3.95 4 miles
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) Allergan Recruiting
3
Trial Phase
1050
Trial Size
3.95 4 miles
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
356
Trial Size
3.95 4 miles
A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Vertex Pharmaceuticals Incorporated Recruiting
2
Trial Phase
105
Trial Size
3.95 4 miles
MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home Cambridge Health Alliance Recruiting N/A
135
Trial Size
3.95 4 miles
Innovative Methods to Assess Psychotherapy Practices (imAPP) Palo Alto Veterans Institute for Research Recruiting N/A
480
Trial Size
3.95 4 miles
North American Prodromal Synucleinopathy Consortium Washington University School of Medicine Recruiting N/A
300
Trial Size
3.95 4 miles
Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers Osiris Therapeutics Recruiting N/A
200
Trial Size
3.95 4 miles
A Study of MTAU9937A in Patients With Moderate Alzheimer's Disease Genentech, Inc. Recruiting
2
Trial Phase
260
Trial Size
3.95 4 miles
Smoking Cessation Intervention for Women Living With HIV University of Massachusetts, Boston Recruiting N/A
50
Trial Size
4.02 4 miles
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV University of Massachusetts, Boston Recruiting
1
Trial Phase
50
Trial Size
4.02 4 miles
Forms of Racial Discrimination Study University of Massachusetts, Boston Recruiting N/A
100
Trial Size
4.02 4 miles
Pilot Study of Multi-wavelength Laser for Tattoo Removal Cutera Inc. Recruiting N/A
75
Trial Size
4.19 4 miles
Iwin: Individual Well-Being Navigator Pro-Change Behavior Systems Recruiting N/A
812
Trial Size
4.19 4 miles
Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis Zimmer Biomet Recruiting N/A
246
Trial Size
4.19 4 miles
Hunter Outcome Survey (HOS) Shire Recruiting N/A
2000
Trial Size
4.19 4 miles
ReNu™ Marrow Stimulation Augmentation NuTech Medical, Inc Recruiting N/A
8
Trial Size
4.19 4 miles
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults Ferring Pharmaceuticals Recruiting
2
Trial Phase
300
Trial Size
4.19 4 miles
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine Tian Medical Inc. Recruiting
3
Trial Phase
180
Trial Size
4.19 4 miles
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) Allergan Recruiting
3
Trial Phase
700
Trial Size
4.19 4 miles
Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain Sorrento Therapeutics, Inc. Recruiting
1
Trial Phase
36
Trial Size
4.19 4 miles
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo Shire Recruiting
3
Trial Phase
284
Trial Size
4.19 4 miles
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia Eli Lilly and Company Recruiting
2
Trial Phase
380
Trial Size
4.19 4 miles
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo Shire Recruiting
3
Trial Phase
930
Trial Size
4.19 4 miles
Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom Brandeis University Recruiting N/A
30
Trial Size
4.19 4 miles
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo Shire Recruiting
3
Trial Phase
721
Trial Size
4.19 4 miles
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) Hoffmann-La Roche Recruiting
3
Trial Phase
600
Trial Size
4.19 4 miles
Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia Eisai Inc. Recruiting
2
Trial Phase
125
Trial Size
4.19 4 miles
A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy Janssen Research & Development, LLC Recruiting
2
Trial Phase
280
Trial Size
4.19 4 miles
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder Sunovion Recruiting
3
Trial Phase
480
Trial Size
4.19 4 miles
McLean and Genomind Prospective Study Mclean Hospital Recruiting N/A
200
Trial Size
4.19 4 miles
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) Hoffmann-La Roche Recruiting
3
Trial Phase
750
Trial Size
4.19 4 miles
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis Ocular Immunology and Uveitis Foundation Recruiting
4
Trial Phase
20
Trial Size
4.19 4 miles
Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine Sanofi Recruiting
3
Trial Phase
500
Trial Size
4.19 4 miles
Fabry Outcome Survey (FOS) Shire Recruiting N/A
4000
Trial Size
4.19 4 miles
Gaucher Disease Outcome Survey (GOS) Shire Recruiting N/A
1257
Trial Size
4.19 4 miles
CoolSculpting the Flanks Zeltiq Aesthetics Recruiting N/A
320
Trial Size
4.19 4 miles
Evaluation of Prealbumin Levels in Men With Low-T Beckman Coulter, Inc. Recruiting N/A
40
Trial Size
4.19 4 miles
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD Multidisciplinary Association for Psychedelic Studies Recruiting
2
Trial Phase
60
Trial Size
4.19 4 miles
College Mental Health Project Mclean Hospital Recruiting N/A
200
Trial Size
4.19 4 miles
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) Radius Health, Inc. Recruiting
3
Trial Phase
225
Trial Size
4.19 4 miles
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Pulse Biosciences, Inc. Recruiting N/A
75
Trial Size
4.19 4 miles
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
300
Trial Size
4.19 4 miles
Together we Move: A Multi-component Intervention to Increase Physical Activity for Ethnic Minority Older Adults Boston College Recruiting N/A
60
Trial Size
4.19 4 miles
Attention to Variability During Infertility Harvard University Recruiting N/A
160
Trial Size
4.19 4 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
4.19 4 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.